Enrico Duru, Ph.D.
Postdoctoral Fellow, Dermatology and Molecular Cardiology, UT Health Science Center, Dallas, TX
After receiving his Ph.D. in Microbiology and Immunology from The University of Texas Medical Branch in Galveston, Dr. Duru completed postdoctoral fellowships at The University of Texas Southwestern Medical Center and The University of Alabama at Birmingham, where his research endeavors focused on HIV-1 infection kinetics and anti-HIV-1 vaccine development. he continued his postdoctoral research at The University of Texas Medical Branch at Galveston, where his studies centered on the roles of G-protein-coupled signal transduction in allergic asthma and the modulation of immune responses in airway hyperresponsiveness. Dr. Duru joined The Methodist Hospital Research Institute in 2009.
In 2000, Dr. Duru completed a fellowship in molecular cardiology during which he and colleagues developed a mouse model of diabetogenic cardiomyopathy using an αβ-crystallin null mouse system. Dr. Duru continues this line of study at The Methodist Hospital Research Institute with emphasis on metabolic syndrome, pulmonary hypertension, and vascular diabetes.
Pulmonary Hypertension, Metabolic Syndrome, Diabetes, Gene Therapy
Duru EA, Fu Y, Davies MG. Src Regulates Sphingosine-1-Phosphate Mediated Smooth Muscle Cell Migration. J Surg Res. 2011 Aug 10. PMID: 21920544
Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med. 2008 Aug;8(5):437-45